Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498524 · ClinicalTrials.gov registry record
Risk of Life-threatening Heart Rhythm Disturbances in Siblings
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,047
- Enrollment target
NCT00498524: Completed study, sponsored by Duke University.
NCT00498524 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,047 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498524 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,047 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if heredity influences the risk of life-threatening heart rhythms (ventricular tachycardia and ventricular fibrillation) after heart attack (myocardial infarction).
Interventions
- DEVICE ICD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,047 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-02 |
What the finished NCT00498524 record still lists
NCT00498524 is an observational study that tracks outcomes without assigning an intervention. Its 2,047 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which ICD is the first listed.
NCT00498524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00498524 about?
NCT00498524 is a clinical study titled "Risk of Life-threatening Heart Rhythm Disturbances in Siblings". The purpose of this study is to determine if heredity influences the risk of life-threatening heart rhythms (ventricular tachycardia and ventricular fibrillation) after heart attack (myocardial infarction).
What is the current status of trial NCT00498524?
This trial is currently completed. The enrollment target is 2,047 participants. The study started on 2007-07. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00498524?
The interventions under investigation include: ICD (DEVICE).
Who is sponsoring clinical trial NCT00498524?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia